Oct 12 2026 | By: Neighborhood Medical Center
They are blood tests that look for signals shed by tumors, screening for many different cancers from a single draw, including cancers that have no routine screening test at all. Galleri and Cancerguard are the two most widely available in the United States.
They are also frequently misunderstood, which is why this deserves a full explanation rather than a headline.
Neighborhood Medical Center in Addison, Texas can discuss whether one fits your situation as part of a broader wellness evaluation.
Routine screening covers a handful of cancers. Breast, colon, cervical, lung for some people, prostate as a discussion.
That leaves a great many cancers with no screening program at all, which means they are typically found once symptoms appear and the disease has progressed. That gap is the entire reason this category of testing exists.
Tumors shed fragments of DNA and other material into the bloodstream.
These tests look for patterns in that material that suggest a cancer signal is present. When a signal is found, the test also attempts to predict where in the body it likely originated, which gives a physician somewhere to start looking rather than a body-wide search.
These tests are intended to be used in addition to guideline-recommended screening, not as a replacement for it.
That is the manufacturers' own position, and it is worth taking seriously. Keep your mammogram. Keep your colonoscopy. A blood test that screens broadly is not a substitute for tests specifically designed and validated for individual cancers.
Anyone who tells you this lets you skip your regular screening is misinformed.
It means no cancer signal was detected. It does not mean you do not have cancer.
These tests do not detect every cancer, and they detect earlier-stage disease less reliably than later-stage disease. A reassuring result is genuinely reassuring, and it is not a clean bill of health.
A detected signal is not a diagnosis. It is the beginning of a diagnostic workup.
That workup may involve imaging, additional bloodwork, specialist referral, and sometimes a biopsy. It can also conclude with no cancer found, which is a real outcome worth being prepared for emotionally and financially before you order the test.
These tests are currently available by prescription and are not yet FDA approved. Galleri's premarket approval application is under FDA review.
They are generally self-pay. Congress has authorized Medicare reimbursement for multi-cancer detection tests beginning in 2028, contingent on approval, which tells you where the category is heading without telling you what it costs today. Ask the office about current pricing.
Full body MRI comes up in the same conversation and carries a similar shape of trade-off.
It can find things early. It also frequently finds incidental findings, meaning something that looks unusual, turns out to be harmless, and generates a sequence of follow-up scans and anxiety along the way. Major medical organizations do not currently recommend it as routine screening for people without symptoms.
That does not make it useless. It makes it a decision requiring an honest conversation about what you would do with each possible result.
Generally adults over 50, people with meaningful family history, and people who are already current on standard screening and want to go further.
Being up to date on the basics matters. Adding an advanced test while skipping your colonoscopy is doing this backwards.
"I am genuinely interested in this technology," says Dr. Martin G. McElya. "What I am not interested in is a patient walking out thinking a blood test replaced everything else. It adds. It does not substitute."
They are designed to detect signals associated with a wide range of cancer types from one sample, including many with no standard screening test. Detection rates vary considerably by cancer type and by stage.
Generally not at present, since these tests are not yet FDA approved. Coverage is expected to evolve, and Medicare reimbursement has been authorized to begin in 2028 contingent on approval. Check current pricing with the office.
Intended screening intervals are still being established, and the right answer for you depends on your age, risk factors, and what you would do with the results. This belongs in a discussion with your physician rather than a standing subscription.
Neighborhood Medical Center is at 5917 Belt Line Road in Addison, Texas, open seven days a week. Call or text 972-726-6464, or book an appointment online.